European Government Expenditure on R&D in Medical and Health Sciences Share by Country (Million Euros)

In 2023, Germany leads in European government expenditure on R&D in medical and health sciences, contributing significantly with 52.77 million Euros, marking an 11.55% year-on-year increase. Spain follows with 22.69 million Euros, up by 5.12%. Italy and Portugal show modest increases of 4.11% and 4.77% respectively. The Netherlands reports a notable decline in investment, decreasing by 7.53%. Finland also experiences a reduction of 4.3%, contrasting with positive albeit smaller growth seen in Estonia, Latvia, Lithuania, and Slovakia, with Slovakia seeing the highest boost at 10.02%. Longer-term, the cumulative annual growth rate has varied widely, highlighting disparate national priorities and economic circumstances influencing R&D investments.

Future trends indicate that countries like Germany and Spain will likely continue increasing their R&D investments given their current upward trajectories. The divergence in national policies and economic capacities will shape investment patterns, with countries facing economic pressures or political shifts potentially altering their funding strategies. Technological advancements, rising healthcare challenges, and EU policies will significantly influence expenditure dynamics across Europe.